Literature DB >> 24927704

PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: a new approach.

Roger Delabio1, Lucas Rasmussen2, Igor Mizumoto1, Gustavo-Arruda Viani1, Elizabeth Chen3, João Villares3, Isabela-Bazzo Costa1, Gustavo Turecki4, Sandra Aparecido Linde5, Marilia Cardoso Smith3, Spencer-Luiz Payão6.   

Abstract

Presenilin 1 (PSEN1) and presenilin 2 (PSEN2) genes encode the major component of y-secretase, which is responsible for sequential proteolytic cleavages of amyloid precursor proteins and the subsequent formation of amyloid-β peptides. 150 RNA samples from the entorhinal cortex, auditory cortex and hippocampal regions of individuals with Alzheimer's disease (AD) and controls elderly subjects were analyzed with using real-time rtPCR. There were no differences between groups for PSEN1 expression. PSEN2 was significantly downregulated in the auditory cortex of AD patients when compared to controls and when compared to other brain regions of the patients. Alteration in PSEN2 expression may be a risk factor for AD.

Entities:  

Keywords:  Alzheimer's disease; brain; gene expression; presenilin-1; presenilin-2; γ-secretase

Mesh:

Substances:

Year:  2014        PMID: 24927704     DOI: 10.3233/JAD-140033

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  Metals toxicity and its correlation with the gene expression in Alzheimer's disease.

Authors:  Jyoti Yadav; Anoop Kumar Verma; Md Kaleem Ahmad; Ravindra K Garg; Abbas Ali Mahdi; Shrikant Srivastava
Journal:  Mol Biol Rep       Date:  2021-05-10       Impact factor: 2.316

Review 2.  Mitochondrial Biology and Neurological Diseases.

Authors:  Siddharth Arun; Lei Liu; Gizem Donmez
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

3.  Familial Alzheimer's Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants.

Authors:  Joanna Wojsiat; Katarzyna Laskowska-Kaszub; Carolina Alquézar; Emilia Białopiotrowicz; Noemi Esteras; Mykola Zdioruk; Angeles Martin-Requero; Urszula Wojda
Journal:  Mol Neurobiol       Date:  2016-09-19       Impact factor: 5.590

4.  Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Olaia Martínez-Iglesias; Vinogran Naidoo; Iván Carrera; Ramón Cacabelos
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

5.  Hypothermia after Perinatal Asphyxia Does Not Affect Genes Responsible for Amyloid Production in Neonatal Peripheral Lymphocytes.

Authors:  Agata Tarkowska; Wanda Furmaga-Jabłońska; Jacek Bogucki; Janusz Kocki; Ryszard Pluta
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

Review 6.  Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease.

Authors:  Ibtisam Mumtaz; Mir Owais Ayaz; Mohamad Sultan Khan; Umar Manzoor; Mohd Azhardin Ganayee; Aadil Qadir Bhat; Ghulam Hassan Dar; Badrah S Alghamdi; Anwar M Hashem; Mohd Jamal Dar; Gulam Md Ashraf; Tariq Maqbool
Journal:  Front Aging Neurosci       Date:  2022-09-07       Impact factor: 5.702

7.  Genetic associations of in vivo pathology influence Alzheimer's disease susceptibility.

Authors:  Jieun Seo; Min Soo Byun; Dahyun Yi; Jun Ho Lee; So Yeon Jeon; Seong A Shin; Yu Kyeong Kim; Koung Mi Kang; Chul-Ho Sohn; Gijung Jung; Jong-Chan Park; Sun-Ho Han; Jayoung Byun; Inhee Mook-Jung; Dong Young Lee; Murim Choi
Journal:  Alzheimers Res Ther       Date:  2020-11-19       Impact factor: 6.982

8.  Deciphering the Forebrain Disorder in a Chicken Model of Cerebral Hernia.

Authors:  Yingfeng Tao; Xiaoliu Zhou; Xinting Zheng; Shijun Li; Chunyan Mou
Journal:  Genes (Basel)       Date:  2020-08-27       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.